SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?


To: Tenchusatsu who wrote (1453948)4/26/2024 12:14:38 PM
From: maceng21 Recommendation

Recommended By
longz

  Respond to of 1577593
 
<<we have a three-phase trial process>>

That sounds promising. Is there any place an interested member of the public with an inquiring mind can see an executive summary of the trials ?



To: Tenchusatsu who wrote (1453948)4/26/2024 2:32:33 PM
From: maceng21 Recommendation

Recommended By
longz

  Read Replies (1) | Respond to of 1577593
 
<< Good thing we have a three-phase trial process>>

There seems to be criticism of the third phase of the AZ COVID vaccine trials. (2020)

AZD1222 Oxford Phase III trials interim analysis results published in The Lancet (astrazeneca.com)




To: Tenchusatsu who wrote (1453948)4/26/2024 5:42:53 PM
From: Doren1 Recommendation

Recommended By
pocotrader

  Read Replies (1) | Respond to of 1577593
 
> Good thing we have a three-phase trial process that is well-documented and highly regulated when it comes to experimental vaccines.

MAGAs are either ignorant or lie about this.

The mRNA vaccines were extensively tested with thousands of volunteers. No more "experimental" than any new drug or vaccine.

In any case Magas have a list of things created by propagandists to whine about, 90% made up & propagated by pop up fake news sites... no matter what the solid evidence to the contrary.

They would complain someone was having fun if ordered.

My advice for them: DON'T GET VACCINATED.

Its helping out on US demographics.